Omega Laboratories Ltd
₹
None%
- close price
About
[
edit about
]
[
add key points
]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE -8.36 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Mar 2006 | Mar 2007 | |
|---|---|---|
| 0.00 | 0.00 | |
| 0.07 | 0.04 | |
| Operating Profit | -0.07 | -0.04 |
| OPM % | ||
| 0.13 | 0.01 | |
| Interest | 0.00 | 0.00 |
| Depreciation | 0.50 | 0.43 |
| Profit before tax | -0.44 | -0.46 |
| Tax % | 0.00% | 0.00% |
| -0.44 | -0.46 | |
| EPS in Rs | ||
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Mar 2006 | Mar 2007 | |
|---|---|---|
| Equity Capital | 6.97 | 6.97 |
| Reserves | -15.84 | -16.30 |
| 14.60 | 14.60 | |
| 0.08 | 0.08 | |
| Total Liabilities | 5.81 | 5.35 |
| 3.67 | 3.24 | |
| CWIP | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 |
| 2.14 | 2.11 | |
| Total Assets | 5.81 | 5.35 |
Cash Flows
Figures in Rs. Crores
| Mar 2006 | Mar 2007 | |
|---|---|---|
| Net Cash Flow |
Ratios
Figures in Rs. Crores
| Mar 2006 | Mar 2007 | |
|---|---|---|
| Debtor Days | ||
| Inventory Days | 0.00 | |
| Days Payable | ||
| Cash Conversion Cycle | ||
| Working Capital Days | ||
| ROCE % | -8.36% |
Documents
Announcements
No data available.
Annual reports
No data available.